Improvement in the clinical outcome of lung cancer is likely to be achieved by identification
of the molecular events that underlie its pathogenesis. Here we show that a small inversion …

Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …

The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura,
Thymus and Heart has just been published with numerous important changes from the 2004 …

Background Epidemiological and clinical evidence suggests that an increased intake of long-chain
n-3 fatty acids protects against mortality from coronary artery disease. We aimed to …

Obesity has become more prevalent in most developed countries over the past few decades,
and is increasingly recognized as a major risk factor for several common types of cancer 1 . …

Through an integrated molecular- and histopathology-based screening system, we performed
a screening for fusions of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1, …

<p id="p001">The EML4 (echinoderm microtubule-associated protein-like 4)–ALK (anaplastic
lymphoma kinase) fusion-type tyrosine kinase is an oncoprotein found in 4 to 5% of non–…

Purpose: EML4-ALK is a transforming fusion tyrosine kinase, several isoforms of which have
been identified in lung cancer. Immunohistochemical detection of EML4-ALK has proved …

EML4-ALK is a fusion-type protein tyrosine kinase that is generated in human non-small-cell
lung cancer (NSCLC) as a result of a recurrent chromosome inversion, inv ( 2 )(p21p23). …

A20 is a negative regulator of the NF-κB pathway and was initially identified as being rapidly
induced after tumour-necrosis factor-α stimulation 1 . It has a pivotal role in regulation of the …